Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yaopin International is a specialized regulatory consultancy and Contract Research Organization (CRO) that facilitates the entry of global pharmaceutical and medical device products into the Chinese market. Headquartered in Beijing, the firm provides end-to-end services including NMPA registration, clinical trial management, and strategic market access consulting. The company is notably active in the Hainan Boao Lecheng International Medical Tourism Pilot Zone, where it helps international manufacturers leverage fast-track approval pathways for innovative medicines and orphan drugs. Yaopin International serves as a strategic bridge for foreign biotechs, navigating China's complex legal and regulatory environment to accelerate product commercialization. Their expertise spans various high-need therapeutic areas, including oncology, cardiology, and high-end medical consumables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yaopin International.